Peak Bio, Inc. Warrant
PKBOW
PKBOW was delisted on the 5th of January, 2023.
5 hedge funds and large institutions have $28K invested in Peak Bio, Inc. Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 10 closing their positions.
67% less funds holding
Funds holding: 15 → 5 (-10)
86% less capital invested
Capital invested by funds: $204K → $28K (-$176K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 10
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$73.4K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$20.5K |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
-$14K |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$7K |
| 5 |
Jane Street
New York
|
-$5.17K |
PKBOW Hedge Fund Activity: Q1 2023 in Review
5 of the 6,285 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q1 2023, worth a combined $28K — down 86% from $204K a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of PKBOW and 0 opened new positions — a net loss of 10 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Deerfield Management, exiting entirely with an estimated $73.4K sold.
- 5 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q1 2023, down from 15 in Q4 2022.
- Funds reported $28K of Peak Bio, Inc. Warrant stock for Q1 2023, down 86% quarter-over-quarter.
- 0 funds opened new Peak Bio, Inc. Warrant positions in Q1 2023 and 10 closed out, a net change of -10 holders.
- The largest Peak Bio, Inc. Warrant seller in Q1 2023 was Deerfield Management, an estimated $73.4K sold.
Based on aggregated 13F filings for Q1 2023.